The cannabis industry has been incredibly lucrative for some time now as regulations continue to change and the public sentiment shifts as well. But as new companies begin to invest billions into larger cannabis stocks, it appears as though the little guys in the industry are seeing a large part of these gains as well. Many of these smaller market cap companies have a large amount of innovation to offer, but most institutional investors only look at the companies that are listed on major exchanges such as the NASDAQ and NYSE.
The company LGC Capital Ltd. (TSXV:LG) is one of the stocks that many investors have been watching for some time now. The company is a large investor in the emerging cannabis market, and has been putting a lot of their money into the international space as well as companies that work within the international markets for cannabis. According to one report “the Company has made significant investments in cultivation companies within Canada, Tricho-Med Corporation, and Australia, Little Green Pharma, with active pursuits also involving opportunities in southern Africa and Jamaica.” The hopes are that these smaller companies will continue to provide a basis for growth as we move toward the future.
The company GT Biopharma Inc (GTBP) has been another one of the big players in the cannabis space for some time now. As a producer and researcher of how to use cannabis components in a variety of pharmaceutical medicines, GT is one of only a few companies that have such a solid amount of exposure to the biotech side of the industry. The company has continued to show their support for the research into various ailments that are otherwise untreatable by traditional forms of medicine. GT continues to be a solid place to start for any investor looking to invest in cannabis for the long term.
The company Golden Leaf Holdings (CSE: GLH ) is a cannabis company that is based out of the U.S. and has been one of the largest cannabis oil producers throughout North America. According to one report “Golden Leaf holds three manufacturing licenses in three states: Nevada, Oregon, and California. On August 13, 2018, the Company agreed to purchase the assets of Tahoe Hydroponics Company along with its 28,800 sq. ft. cultivation facility that currently under development.” This massive trend toward growth in the future continues to show their commitment to being apart of the coming years for the cannabis market.
Cannabis as a whole continues to present a large amount of opportunity as the industry is just beginning to take shape. The hopes are high that in the near future, with new legislation these companies will be able to maintain their growth trends along with the whole of the cannabis market.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
